Primary sclerosing cholangitis under aspects of translational neurology, mental health, and systemic inflammation.

Primary sclerosing cholangitis under aspects of translational neurology, mental health, and systemic inflammation. - PATHwayS

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00025588

Enrollment

120

Registered

2023-01-17

Start date

2022-03-29

Completion date

Unknown

Last updated

2026-03-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Primary sclerosing cholangitis K83.00 K83.1

Interventions

Group 1: Patients with PSC will undergo a one-time QoL questionnaire and neurological examination. Endoscopic data are collected retrospectively from the clinic database

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: PSC, Adult (18 years), Informed Consent

Exclusion criteria

Exclusion criteria: Refusal, non-business capacity

Design outcomes

Primary

Measure	Time frame
Characterization of endoscopic, psychosomatic and neurological changes in PSC.	—

Secondary

Measure	Time frame
Endoscopic intervention/complication ERCP, QoL, frequency of central and peripheral functional neurologic abnormalities.	—

Countries

Germany

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Mar 14, 2026